GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GC Cell Corp (XKRX:144510) » Definitions » Ending Cash Position

GC Cell (XKRX:144510) Ending Cash Position : ₩2,337 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is GC Cell Ending Cash Position?

GC Cell's Ending Cash Position for the quarter that ended in Mar. 2025 was ₩2,337 Mil.

GC Cell's quarterly Ending Cash Position declined from Sep. 2024 (₩5,337 Mil) to Dec. 2024 (₩5,041 Mil) and declined from Dec. 2024 (₩5,041 Mil) to Mar. 2025 (₩2,337 Mil).

GC Cell's annual Ending Cash Position declined from Dec. 2022 (₩47,374 Mil) to Dec. 2023 (₩12,558 Mil) and declined from Dec. 2023 (₩12,558 Mil) to Dec. 2024 (₩5,041 Mil).

GC Cell Ending Cash Position Historical Data

The historical data trend for GC Cell's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GC Cell Ending Cash Position Chart

GC Cell Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,118.59 18,003.93 47,374.24 12,557.66 5,040.57

GC Cell Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,352.29 10,481.60 5,337.05 5,040.57 2,336.67

GC Cell Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

GC Cell's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=12557.663+-7517.092
=5,041

GC Cell's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=5040.571+-2703.899
=2,337

GC Cell Ending Cash Position Related Terms

Thank you for viewing the detailed overview of GC Cell's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

GC Cell Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GC Cell Corp (XKRX:144510) » Definitions » Ending Cash Position
Comparable Companies
XKRX:950130 XKRX:038290 XKRX:051980 XKRX:084650 XKRX:217330 XKRX:376930 XKRX:180400 XKRX:153710 XKRX:384470 XKRX:363250 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT
Traded in Other Exchanges
N/A
Address
30 beongil to giheung-gu, Gyeonggi, 107 Lee Hyun, Yongin, KOR, 16 924
Website
https://www.gccell.com
GC Cell Corp engages in the provision of anti-cancer immunotherapy. The company is developing an anticancer drug, which is in Phase II clinical trials; and stem cell treatment drugs. It also provides cell banking, sample inspection, clinical trial, and bio logistics services.

GC Cell Headlines

No Headlines